Home Infusion Therapy Accreditation: Comparing Accreditation Options
Home infusion therapy providers face a complex accreditation landscape — with CMS Medicare enrollment requirements under the 21st Century Cures Act, commercial payer credentialing requirements, and pharmacy-specific accreditation programs all potentially applicable. This comparison helps providers navigate the options.
The Home Infusion Accreditation Landscape
Home infusion providers often need to hold multiple accreditations simultaneously — or select an accreditation portfolio that satisfies multiple requirements. The primary programs to consider:
- ACHC Home Infusion Therapy Accreditation — CMS-approved for Medicare Part B home infusion therapy benefit enrollment
- URAC Specialty Pharmacy Accreditation — commercial payer network access for specialty drug programs
- ACHC Pharmacy Accreditation — covers pharmacy operations including home infusion pharmacy
- NABP Accreditation — pharmacy-specific, state board recognition
- The Joint Commission Home Infusion Accreditation — CMS-approved for Medicare, hospital system recognition
| Factor | ACHC Home Infusion | TJC Home Infusion | URAC Specialty Pharmacy |
|---|---|---|---|
| CMS Medicare Part B Enrollment | Yes (CMS-approved) | Yes (CMS-approved) | No (commercial focus) |
| Commercial Payer Recognition | Growing | Broad | Broad (specialty PBMs) |
| Standards Focus | Clinical services + CoP compliance | Patient safety + NPSGs + CoPs | Specialty drug safety, clinical programs |
| Survey Style | Collaborative, educational | Rigorous, structured | Document-based, clinical program review |
| Pharmacy Operations Coverage | Partial (clinical services focus) | Partial | Comprehensive specialty pharmacy |
ACHC Home Infusion Therapy Accreditation
ACHC is one of the CMS-approved accreditors for the Medicare home infusion therapy benefit under the 21st Century Cures Act. ACHC's standards are focused on the clinical service delivery aspects of home infusion — patient assessment, nursing services, pharmacist oversight, training, and 24/7 support — rather than the full pharmacy operations framework.
When ACHC Home Infusion Is the Right Choice
- Provider's primary goal is Medicare Part B enrollment for the home infusion therapy benefit
- Organization is a clinical home infusion services provider, not primarily a compounding pharmacy
- Provider also holds or is pursuing ACHC pharmacy or DMEPOS accreditation for a consolidated survey experience
Joint Commission Home Infusion Accreditation
TJC is also CMS-approved for the Medicare home infusion therapy benefit and brings its National Patient Safety Goals framework to the home infusion setting. TJC is the preferred choice for home infusion providers affiliated with hospital systems or health networks where TJC recognition is a purchasing or contracting criterion.
When TJC Home Infusion Is the Right Choice
- Provider has strong hospital system relationships where TJC recognition is valued
- Provider is part of a health system that already holds TJC accreditation across other service lines
- Provider wants the broadest name recognition across both Medicare and commercial payer networks
URAC Specialty Pharmacy Accreditation
URAC Specialty Pharmacy Accreditation is the dominant accreditation for specialty pharmacy programs, including infusion pharmacy operations serving complex chronic and rare disease patients. URAC accreditation is required by many specialty PBMs and commercial payers for specialty network participation — but does not satisfy the CMS Medicare home infusion therapy benefit enrollment requirement.
When URAC Specialty Pharmacy Is the Right Choice
- Provider's primary market is commercial specialty pharmacy contracts through PBMs
- Provider needs to access specialty formulary contracts where URAC is the network credential
- Provider may need BOTH URAC (commercial) and ACHC or TJC (Medicare) to cover the full payer landscape
When Dual Accreditation Is Required
Many home infusion providers need both a CMS-approved accreditation (ACHC or TJC) for Medicare enrollment AND URAC or NABP accreditation for commercial payer network access. IHS has experience designing accreditation portfolios that satisfy both requirements efficiently — identifying overlapping standards that can be addressed through a single documentation and policy development effort rather than two parallel processes.
Choosing the Right Home Infusion Accreditation Portfolio
- Start with payer requirements: List every payer whose network you need to participate in and identify which accreditations each requires. This determines your minimum accreditation portfolio.
- Evaluate standards overlap: ACHC Home Infusion and URAC Specialty Pharmacy have significant standards overlap in clinical program design, pharmacist oversight, and quality management. A coordinated preparation approach reduces total effort.
- Consider organizational structure: Providers that operate both dispensing pharmacy and clinical services may need ACHC Pharmacy (or NABP) for the dispensing side plus ACHC Home Infusion Therapy for the clinical services side.
IHS Home Infusion Accreditation Consulting
IHS provides consulting for ACHC Home Infusion Therapy Accreditation, URAC Specialty Pharmacy Accreditation, and NABP accreditation. For providers pursuing multiple accreditations, IHS designs an integrated preparation approach that addresses all programs efficiently. IHS is led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC — with direct knowledge of URAC specialty pharmacy standards alongside ACHC expertise.
Schedule a Free Discovery Session
Navigating home infusion therapy accreditation options? IHS can help you map payer requirements to the right accreditation portfolio and prepare efficiently. The first conversation is free.
Schedule a Free Discovery Session